These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12914943)

  • 21. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
    Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
    PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.
    Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L
    Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.
    Kwon JA; Rho HM
    Biol Chem; 2003 Feb; 384(2):203-12. PubMed ID: 12675512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions.
    Chambers MA; Dougan G; Newman J; Brown F; Crowther J; Mould AP; Humphries MJ; Francis MJ; Clarke B; Brown AL; Rowlands D
    J Virol; 1996 Jun; 70(6):4045-52. PubMed ID: 8648742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of the interaction between the envelope protein domains and the core protein of human hepatitis B virus.
    Choi KJ; Lim CW; Yoon MY; Ahn BY; Yu YG
    Biochem Biophys Res Commun; 2004 Jul; 319(3):959-66. PubMed ID: 15184075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression.
    Du J; Liang X; Liu Y; Qu Z; Gao L; Han L; Liu S; Cui M; Shi Y; Zhang Z; Yu L; Cao L; Ma C; Zhang L; Chen Y; Sun W
    Cell Death Differ; 2009 Feb; 16(2):219-29. PubMed ID: 18927587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allosteric conformational changes of human HBV core protein transform its assembly.
    Liu C; Fan G; Wang Z; Chen HS; Yin CC
    Sci Rep; 2017 May; 7(1):1404. PubMed ID: 28469174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleotide sequence of the precore/core gene and X gene of hepatitis B virus DNA in asymptomatic hepatitis B virus carriers who are negative for serum hepatitis B core antibody.
    Terada T; Moriyama M; Uchida T; Arakawa Y
    Intervirology; 2001; 44(4):243-9. PubMed ID: 11509887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteasomal degradation of core protein variants from chronic hepatitis B patients.
    Braun S; Zajakina A; Aleksejeva J; Sharipo A; Bruvere R; Ose V; Pumpens P; Garoff H; Meisel H; Kozlovska T
    J Med Virol; 2007 Sep; 79(9):1312-21. PubMed ID: 17607782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3.5Å cryoEM structure of hepatitis B virus core assembled from full-length core protein.
    Yu X; Jin L; Jih J; Shih C; Zhou ZH
    PLoS One; 2013; 8(9):e69729. PubMed ID: 24039702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris.
    Freivalds J; Dislers A; Ose V; Pumpens P; Tars K; Kazaks A
    Protein Expr Purif; 2011 Feb; 75(2):218-24. PubMed ID: 20854910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping of homologous interaction sites in the hepatitis B virus core protein.
    König S; Beterams G; Nassal M
    J Virol; 1998 Jun; 72(6):4997-5005. PubMed ID: 9573269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
    Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
    J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene.
    Günther S; Piwon N; Jung A; Iwanska A; Schmitz H; Will H
    Virology; 2000 Aug; 273(2):286-99. PubMed ID: 10915599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mosaic amino acid conservation in 3D-structures of surface protein and polymerase of hepatitis B virus.
    van Hemert FJ; Zaaijer HL; Berkhout B; Lukashov VV
    Virology; 2008 Jan; 370(2):362-72. PubMed ID: 17935747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermodynamic origins of protein folding, allostery, and capsid formation in the human hepatitis B virus core protein.
    Alexander CG; Jürgens MC; Shepherd DA; Freund SM; Ashcroft AE; Ferguson N
    Proc Natl Acad Sci U S A; 2013 Jul; 110(30):E2782-91. PubMed ID: 23824290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Woodchuck hepatitis virus core gene deletions and proliferative responses of peripheral blood mononuclear cells stimulated by an immunodominant epitope: a viral immune escape in the woodchuck model of chronic hepatitis B?
    Taffon S; Kondili LA; Giuseppetti R; Ciccaglione AR; Pulimanti B; Attili AF; Rapicetta M; D'Ugo E
    Arch Virol; 2015 Apr; 160(4):1065-73. PubMed ID: 25666197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.
    Strods A; Ose V; Bogans J; Cielens I; Kalnins G; Radovica I; Kazaks A; Pumpens P; Renhofa R
    Sci Rep; 2015 Jun; 5():11639. PubMed ID: 26113394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of a putative intermolecular interaction between core and the pre-S1 domain of the large envelope protein on hepatitis B virus secretion.
    Le Pogam S; Shih C
    J Virol; 2002 Jul; 76(13):6510-7. PubMed ID: 12050364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yield Optimisation of Hepatitis B Virus Core Particles in E. coli Expression System for Drug Delivery Applications.
    Bin Mohamed Suffian IF; Garcia-Maya M; Brown P; Bui T; Nishimura Y; Palermo AR; Ogino C; Kondo A; Al-Jamal KT
    Sci Rep; 2017 Mar; 7():43160. PubMed ID: 28256592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.